Cargando…

Real-World Treatment Patterns of Antiviral Prophylaxis for Cytomegalovirus Among Adult Kidney Transplant Recipients: A Linked USRDS-Medicare Database Study

Limited data exist on cytomegalovirus (CMV) antiviral treatment patterns among kidney transplant recipients (KTRs). Using United States Renal Database System registry data and Medicare claims (1 January 2011–31 December 2017), we examined CMV antiviral use in 22,878 KTRs who received their first KT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raval, Amit D., Ganz, Michael L., Fraeman, Kathy, Lorden, Andrea L., Saravanan, Shanmugapriya, Tang, Yuexin, Santos, Carlos A. Q.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Health Archive
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421942/ https://www.ncbi.nlm.nih.gov/pubmed/36046353 http://dx.doi.org/10.3389/ti.2022.10528

Ejemplares similares

Expression of Concern: Real-World Treatment Patterns of Antiviral Prophylaxis for Cytomegalovirus Among Adult Kidney Transplant Recipients: A Linked USRDS-Medicare Database Study
Publicado: (2023)

1387. Impact of Cytomegalovirus Prophylaxis on Healthcare Resource Use and Costs among Kidney Transplant Recipients: A United States Renal Data System-Medicare Linked Database Study
por: Raval, Amit D, et al.
Publicado: (2021)

1378. Impact of Cytomegalovirus Prophylaxis on Clinical Outcomes in Kidney Transplantation: A United States Renal Data System-Medicare Linked Database Study
por: Raval, Amit D, et al.
Publicado: (2021)

1380. Real-world Effectiveness and Complications of Valganciclovir (VGC) Prophylaxis for Kidney Transplant (KT) Recipients at High Risk for Cytomegalovirus (CMV) infection (CMV Donor (D)+/Recipient (R)-)
por: Roumpz, Caroline G, et al.
Publicado: (2021)

Association Between Cytomegalovirus Serostatus, Antiviral Therapy, and Allograft Survival in Pediatric Heart Transplantation
por: Rabbani, Naveed, et al.
Publicado: (2022)

Factors Associated With Genotypic Resistance and Outcome Among Solid Organ Transplant Recipients With Refractory Cytomegalovirus Infection
por: Tamzali, Yanis, et al.
Publicado: (2023)

Real-World Outcomes Associated With Letermovir Use for Cytomegalovirus Primary Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients: A Systematic Review and Meta-analysis of Observational Studies
por: Vyas, Ami, et al.
Publicado: (2022)

Cytomegalovirus Management in Solid Organ Transplant Recipients: A Pre-COVID-19 Survey From the Working Group of the European Society for Organ Transplantation
por: Grossi, Paolo Antonio, et al.
Publicado: (2022)

Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience
por: Selvey, Linda A., et al.
Publicado: (2017)

Antiviral prophylaxis inhibits cytomegalovirus reactivation in critical illness
por: Cowley, NJ, et al.
Publicado: (2015)

Cytomegalovirus Cell-Mediated Immunity: Ready for Routine Use?
por: Bestard, Oriol, et al.
Publicado: (2023)

1109. Valgancyclovir Dosing for Cytomegalovirus Prophylaxis in Heart Transplant Recipients
por: Huang, Glen, et al.
Publicado: (2020)

HIVAN and medication use in chronic dialysis patients in the United States: analysis of the USRDS DMMS Wave 2 study
por: Abbott, Kevin C, et al.
Publicado: (2003)

Living Donor Kidney Transplant in Recipients With Glomerulonephritis: Donor Recipient Biologic Relationship and Allograft Outcomes
por: El-Rifai, Rasha, et al.
Publicado: (2023)

Association between Antiviral Prophylaxis and Cytomegalovirus and Epstein–Barr Virus DNAemia in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplant
por: Diop, Ndeye Soukeyna, et al.
Publicado: (2021)

Cytomegalovirus Disease as a Risk Factor for Invasive Fungal Infections in Liver Transplant Recipients under Targeted Antiviral and Antimycotic Prophylaxis
por: Breitkopf, Robert, et al.
Publicado: (2023)

Post-Transplantation Cytomegalovirus Infection Interplays With the Development of Anastomotic Biliary Strictures After Liver Transplantation
por: Georges, Pauline, et al.
Publicado: (2022)

Soluble Urokinase Receptor and Mortality in Kidney Transplant Recipients
por: Morath, Christian, et al.
Publicado: (2022)

Matching Donor and Recipient Size in Pediatric Heart Transplantation
por: Singh, Tajinder P., et al.
Publicado: (2022)

Hearing Impairments as an Overlooked Condition in Kidney Transplant Recipients
por: Simsir, Melis, et al.
Publicado: (2022)

Living Donor Liver Transplantation vs. Split Liver Transplantation Using Left Lateral Segment Grafts in Pediatric Recipients: An Analysis of the UNOS Database
por: Dalzell, Christina, et al.
Publicado: (2022)

Tremor, Daily Functioning, and Health-Related Quality of Life in Solid Organ Transplant Recipients
por: Riemersma, Niels L., et al.
Publicado: (2023)

The Clinical Impact of Anti-HLA Donor Specific Antibody Detection Through First Year Screening on Stable Kidney Transplant Recipients
por: Sharma, Akhil, et al.
Publicado: (2022)

Cytokine and Chemokine Secretome and Risk of CMV Infection Following Discontinuation of Valganciclovir Prophylaxis
por: Fernández-Ruiz, Mario, et al.
Publicado: (2023)

Effectiveness of valacyclovir prophylaxis against the occurrence of cytomegalovirus infection in kidney transplant recipients
por: Park, Woo Yeong, et al.
Publicado: (2020)

Association of restless legs syndrome and mortality in end-stage renal disease: an analysis of the United States Renal Data System (USRDS)
por: DeFerio, Joseph J., et al.
Publicado: (2017)

A Kidney Transplant Recipient on Prophylactic Eculizumab Presenting With Myalgia
por: Shivakumar, Oshini, et al.
Publicado: (2022)

568. Healthcare Cost and Length of Stay for Cytomegalovirus (CMV) Infection-Related Hospitalizations in Allogeneic Hematopoietic Cell Transplant (allo-HCT) recipients: A Multicenter Analysis
por: Khawaja, Fareed, et al.
Publicado: (2020)

Excess Mortality in Kidney and Kidney-Pancreas Transplant Recipients in the COVID-19 Pandemic in Portugal—A Cohort Study
por: Coimbra, Miguel T., et al.
Publicado: (2023)

Treatment With Diflunisal in Domino Liver Transplant Recipients With Acquired Amyloid Neuropathy
por: Nedkova-Hristova, Velina, et al.
Publicado: (2022)

210. Neutropenia and Associated Infectious Complications Among Kidney Transplant Recipients Receiving Valganciclovir Prophylaxis in the United States: An Administrative Claims Database Study
por: Turzhitsky, Vladimir, et al.
Publicado: (2022)

Tacrolimus Monotherapy is Safe in Immunologically Low-Risk Kidney Transplant Recipients: A Randomized-Controlled Pilot Study
por: de Weerd, Annelies E., et al.
Publicado: (2022)

MiR-21 in Lung Transplant Recipients With Chronic Lung Allograft Dysfunction
por: Miyahara, Naofumi, et al.
Publicado: (2022)

Urological Complications Associated With Pyeloureterostomy Without Ipsilateral Nephrectomy in Renal Transplant Recipients
por: Neto, Hernani M., et al.
Publicado: (2022)

Posttransplantation Diabetes Mellitus Among Solid Organ Recipients in a Danish Cohort
por: Dos Santos, Quenia, et al.
Publicado: (2022)

Impact of Size Matching Based on Donor-Recipient Height on Kidney Transplant Outcomes
por: Tandukar, Srijan, et al.
Publicado: (2022)

Normothermic Machine Perfusion—Improving the Supply of Transplantable Livers for High-Risk Recipients
por: Hann, Angus, et al.
Publicado: (2022)

Combined Donor-Recipient Obesity and the Risk of Graft Loss After Kidney Transplantation
por: Jarrar, Faisal, et al.
Publicado: (2022)

SARS-CoV-2 Vaccination-Induced Immunogenicity in Heart Transplant Recipients
por: Memenga, Felix, et al.
Publicado: (2023)

Predictors and Adverse Outcomes of Acute Kidney Injury in Hospitalized Renal Transplant Recipients
por: Hod, Tammy, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2kqqt58k4n00r5h8l0ak544omi